Immunocore Hldgs Q3 EPS $0.04 Down From $0.13 YoY, Sales $60.73M Miss $62.14M Estimate
Portfolio Pulse from Benzinga Newsdesk
Immunocore Hldgs (NASDAQ:IMCR) reported Q3 earnings of $0.04 per share, a 69.23% decrease YoY. The company's quarterly sales were $60.73M, missing the analyst consensus estimate of $62.14M by 2.27%, but representing a 32.39% increase YoY.
November 07, 2023 | 12:10 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Immunocore's Q3 earnings per share decreased by 69.23% YoY, and sales missed estimates by 2.27%, which may negatively impact the stock in the short term.
Immunocore's Q3 earnings per share decreased significantly YoY and sales missed analyst estimates, which are key indicators that investors consider when evaluating a company's performance. This could lead to a decrease in the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100